Morning Overview on MSN
A Harvard scientist says his team is preparing the first human trials aimed at reversing aging
A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...
A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...
For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...
Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...
A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...
The world's first anti-ageing gene therapy has just been injected into a human - here's what it does
First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...
The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
For Beijing-based METiS TechBio CEO Lai Tsai-ta, ageing is comparable to bugs building up in a complex software system – it happens once errors begin to accumulate in the genetic code of human cells, ...
Effects of resorcinol isoprenyl benzene derivative IPI201 on natural killer cell cytotoxicity and tumor cell viability in human colorectal adenocarcinoma cells. An LNP-mRNA–based in vivo cell engager ...
A newly published review article highlights the critical role of fatty acid metabolism in shaping the tumor microenvironment and influencing cancer progression, offering fresh perspectives for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results